2.—(1) In this Part, unless the context otherwise requires —| “allied health professional” has the same meaning as in section 2 of the Allied Health Professions Act (Cap. 6B); |
| “approved allied health professional” means any allied health professional who is approved by the Minister charged with the responsibility for health for the purposes of this Part; [S 855/2020 wef 01/10/2020] |
| “approved centre” means any centre in a hospital or clinic approved by the Minister for Health for renal dialysis treatment; |
| “approved chronic illness treatment” means any medical treatment or psychiatric treatment in respect of any chronic illness which is approved by the Minister for Health for the purposes of this Part; [S 855/2020 wef 01/10/2020] |
| “approved CIT medical institution” means any centre, clinic, hospital or other premises which offers medical treatment or psychiatric treatment and which the Minister for Health has approved for the purposes of approved chronic illness treatments under this Part; [S 855/2020 wef 01/10/2020] |
| “approved clinic” means any medical clinic approved by the Minister for Health for the purposes of this Part; [S 855/2020 wef 01/10/2020] |
| “approved clinical laboratory” means any clinical laboratory within the meaning of section 2 of the Private Hospitals and Medical Clinics Act (Cap. 248) which is approved by the Minister for Health for the purposes of this Part; [S 855/2020 wef 01/10/2020] |
| “approved community hospital” means any premises which, in the opinion of the Minister for Health, provides an intermediate level of care for out-patients and in-patients who have simple ailments which do not require specialist medical and nursing care and is approved by that Minister for the purposes of this Part; [S 855/2020 wef 01/10/2020] |
| “approved convalescent hospital” means any premises which provides in-patient medical care for the recovery or rehabilitation of patients and is approved by the Minister for Health for the purposes of this Part; [S 855/2020 wef 01/10/2020] |
| “approved day hospice” means any premises (other than a home) which are used for out-patient medical treatment and care of terminally ill patients and are approved by the Minister for Health for the purposes of this Part; [S 855/2020 wef 01/10/2020] |
| “approved day hospital” means any premises which provides for day rehabilitative assessment and treatment of patients and is approved by the Minister for Health for the purposes of this Part; [S 855/2020 wef 01/10/2020] |
| “approved day rehabilitation centre” means any centre operating at or within a location other than an approved hospital, which provides approved rehabilitation treatment and is approved by the Minister for Health for the purposes of this Part; [S 855/2020 wef 01/10/2020] |
| “approved day surgery centre” means any centre which provides day surgical treatment to a member or his dependant and is approved by the Minister for Health for the purposes of this Part; [S 855/2020 wef 01/10/2020] |
| “approved home palliative care provider” means any person who provides home palliative care and is approved by the Minister for Health for the purposes of this Part; [S 855/2020 wef 01/10/2020] |
| “approved hospital” means any hospital approved by the Minister for Health for the purposes of this Part; [S 855/2020 wef 01/10/2020] |
| “approved in-patient hospice” means any premises which are used for in-patient medical treatment and care of terminally ill patients and are approved by the Minister for Health for the purposes of this Part; [S 855/2020 wef 01/10/2020] |
| “approved in-patient palliative care service provider” or “approved IPC provider” means any premises that provide in-patient palliative care and are approved by the Minister charged with the responsibility for health for the purposes of this Part; [S 855/2020 wef 01/10/2020] |
“approved medical institution” means any of the following:| (a) | approved centre; | | (b) | approved CIT medical institution; | | (c) | approved clinic; | | (ca) | approved clinical laboratory; | | (d) | approved community hospital; | | (e) | approved convalescent hospital; | | (ea) | approved day hospice; | | (f) | approved day hospital; | | (fa) | approved day rehabilitation centre; | | (g) | approved day surgery centre; | | (i) | approved hospital; | | (ia) | approved in-patient hospice; | | (iaa) | approved IPC provider; | | (ib) | approved Third Schedule treatment provider; | | (j) | School Health Service; | | (l) | Singapore Gamma Knife Centre; |
|
| “approved medical practitioner” means any medical practitioner who is approved by the Minister for Health or such other person as he may appoint for the purposes of this Part; [S 855/2020 wef 01/10/2020] |
| “approved out-patient parenteral nutrition” means any parenteral nutrition that is provided by an approved hospital to an out-patient, and is approved by the Minister for Health for the purposes of this Part; [S 855/2020 wef 01/10/2020] |
| “approved rehabilitation treatment” means any out‑patient rehabilitation treatment that is provided by an approved day rehabilitation centre and is approved by the Minister for Health for the purposes of this Part; [S 855/2020 wef 01/10/2020] |
“approved remote consultation”, in relation to any approved chronic illness treatment provided on an out-patient basis, means any treatment received by a patient from an approved medical practitioner as a patient of an approved CIT medical institution via —| (a) | any video-conferencing service; | | (b) | any website, web service or Internet application; or | | (c) | any other kind of electronic communication or other technology for facilitating communication, |
| that is approved for that treatment by the Minister charged with the responsibility for health; |
|
| “approved renal dialysis premises” means any premises that the Minister charged with the responsibility for health approves for the type of renal dialysis treatment received; [S 157/2021 wef 15/03/2021] |
| “approved screening” means any health screening which is approved by the Minister for Health for the purposes of this Part; [S 855/2020 wef 01/10/2020] |
| “approved Third Schedule treatment provider” means any hospital or medical clinic that provides any Third Schedule treatment and is approved by the Minister for Health for the purposes of this Part; [S 855/2020 wef 01/10/2020] |
“approved treatment package” means a course of one or more of the following which lasts not more than one year, which is approved by the Minister for Health for the purposes of this Part, and which complies with such terms and conditions as the Minister for Health may impose:| (a) | medical treatments; | | (b) | psychiatric treatments; | | (c) | approved rehabilitation treatments; | | (d) | home palliative care; | | (e) | approved screenings; |
[S 855/2020 wef 01/10/2020] |
| “approved vaccination” means any vaccination (including any vaccination against Hepatitis B or pneumococcal disease) which is approved by the Minister for Health for the purposes of this Part; [S 855/2020 wef 01/10/2020] |
| “co-payment amount”, in relation to a member or his dependant, means the amount which the member or his dependant (as the case may be) is responsible for paying in respect of any approved chronic illness treatment or approved treatment package, as specified in regulation 14(1)(a); |
| “co-payment percentage”, in relation to a member or his dependant, means the percentage of the charge for any approved chronic illness treatment or approved treatment package which the member or his dependant (as the case may be) is responsible for paying, as specified in regulation 14(1)(a) and (b); |
| “day surgical treatment” means any surgical treatment received by a person who is admitted and discharged on the same day; |
“dependant”, in relation to a member, means any of the following:| (a) | the member’s spouse; | | (b) | the member’s child; | | (c) | the member’s parent; | | (d) | the member’s grandparent who is a citizen or permanent resident of Singapore; | | (e) | the member’s sibling who is a citizen or permanent resident of Singapore; |
|
| “First Schedule treatment” means any medical treatment specified in the First Schedule; |
| “home”, in relation to a person, means any premises (other than an approved medical institution) in which the person is residing; |
| “home palliative care” means any palliative care for a terminally ill patient provided at the home of the patient; |
“in-patient” means a patient who —| (a) | is hospitalised, for any treatment other than day surgical treatment, for a period of not less than 8 hours; or | | (b) | has died within 8 hours after being hospitalised for any treatment other than day surgical treatment; |
|
| “last medical bill”, in relation to a member who has died on or after 1st July 2006 in an approved medical institution before his discharge therefrom, means the bill for charges incurred in respect of the medical or psychiatric treatments which the member received in the approved medical institution; |
| “living donor organ transplant” has the same meaning as in the Human Organ Transplant Act (Cap. 131A); |
| “medical clinic” means any premises used by one or more approved medical practitioners for the diagnosis or treatment of persons but does not include any such premises which forms part of the premises of an approved hospital; |
| “medical practitioner” means any medical practitioner registered under the Medical Registration Act (Cap. 174) or any dentist registered under the Dental Registration Act (Cap. 76); |
“medical treatment” —| (a) | means —| (i) | any medical treatment, surgical treatment, radiotherapy treatment, treatment of neoplasms by chemotherapy, renal dialysis treatment, radiosurgery treatment or approved vaccination; and | | (ii) | any treatment for any mental illness or personality disorder classified by the Minister for Health as a medical condition; and |
| | (b) | includes —| (i) | any investigation, medicine, curative material or device; and | | (ii) | where any treatment or vaccination referred to in paragraph (a) of this definition has been received by a person as an in-patient of any approved medical institution that is not an approved day rehabilitation centre, the maintenance of that person in the approved medical institution; |
|
|
| “medical treatment for conception” means assisted conception procedures, for example, Invitro Fertilisation (IVF), Gamete Intra-fallopian Transfer (GIFT), etc.; |
| “Medisave healthcare provider” has the same meaning as in section 67A of the Act; |
| “member” includes a member who is an undischarged bankrupt; |
| “non‑qualifying medical treatment” means any medical treatment for which no withdrawal from a medisave account may be made under this Part; [S 855/2020 wef 01/10/2020] |
“organ transplantation costs” means —| (a) | any costs arising in relation or incidental to the removal of any organ from a non-living organ donor for organ transplant and includes the costs of —| (i) | the donor’s extended stay, before his death, in a hospital as necessitated by the donation of his organ; | | (ii) | any surgical operation to remove the organ from the donor’s body; | | (iii) | any pre-harvesting laboratory test and investigation; | | (iv) | any counselling provided to the donor’s family in connection with the donation of his organ; | | (v) | the storage and transport of the organ; and | | (vi) | such other procedure as may be approved by the Minister for Health; or |
| | (b) | any costs so far as are reasonably or directly attributable to the removal of any specified organ from a living organ donor for organ transplant and includes the costs of —| (i) | the donor’s stay in a hospital as necessitated by the donation of his specified organ until he is discharged; | | (ii) | any surgical operation to remove the specified organ from the donor’s body; | | (iii) | the storage and transport of the specified organ; and | | (iv) | such other procedure as may be approved by the Minister for Health, |
| (A) | any costs arising in relation or incidental to complications suffered by the donor due to the donation of his specified organ after his discharge from the hospital under sub-paragraph (i); | | (B) | any pre-harvesting laboratory test and investigation; and | | (C) | any counselling provided to the donor’s family in connection with the donation of his specified organ; |
|
|
| “out-patient” means a patient other than an in-patient or a patient receiving day surgical treatment; |
“out‑patient scan” means any scan which —| (a) | is performed on an out‑patient for the purpose of —| (i) | providing diagnostic imaging to investigate any medical condition of the out‑patient; or | | (ii) | providing clinical information for any non‑qualifying medical treatment or specified out-patient treatment received by the out‑patient; and |
| | (b) | may include magnetic resonance imaging (MRI), computerised tomography (CT) scans, positron emission tomography (PET) scans, ultrasound imaging and mammograms, but does not include the following:| (i) | any cancer scan or diagnostic test defined in regulation 13(7); | | (ii) | any scan for health screening purposes; | | (iii) | any scan not instructed by an approved medical practitioner; | | (iv) | any scan performed at the emergency department of an approved medical institution; |
|
|
| “pre-delivery medical treatment” means any medical treatment prescribed by a medical practitioner that is received by a pregnant woman in relation to her pregnancy before the delivery of a child or the termination of her pregnancy; |
“prescribed person”, in relation to a member, means a person —| (b) | who does not lack capacity within the meaning of section 4 of the Mental Capacity Act (Act 22 of 2008); and | | (c) | who is —| (i) | a deputy appointed or deemed to be appointed for the member by the court under the Mental Capacity Act 2008 with power in relation to the member for the purposes of the Act; | | (ii) | a donee under a lasting power of attorney registered under the Mental Capacity Act 2008 with power in relation to the member for the purposes of the Act; or | | (iii) | the spouse, a parent or a child of the member, or such other person related to the member as the Minister for Health may approve for the purposes of regulation 3 or 17, each being an individual who has attained the age of 21 years; |
|
|
| “psychiatric treatment” includes any therapeutic procedure given to control and relieve any psychiatric symptom or to prevent its recurrence, but does not include any treatment for any mental illness or personality disorder classified by the Minister for Health as a medical condition; |
| “radiosurgery treatment” means the gamma knife treatment or the Novalis shaped beam treatment of neurosurgical or neurological disorders; |
| “radiotherapy treatment” means the treatment of any malignant disease or certain benign condition with ionising radiation delivered externally or internally by sealed or unsealed radionuclides and irradiating apparatus as specified in the First Schedule; |
“renal dialysis treatment” means any of following:| (a) | haemodialysis; | | (b) | continuous ambulatory peritoneal dialysis; | | (c) | automated peritoneal dialysis; | | (d) | any other treatment received for the purpose of purifying the blood of waste metabolites accumulated as a result of renal failure, that is approved by the Minister charged with the responsibility for health for the purposes of this Part; |
[S 157/2021 wef 15/03/2021] |
| “Singapore Gamma Knife Centre” means any premises which provides gamma knife treatment for the care of in-patients and is approved by the Minister for Health for the purposes of this Part; [S 855/2020 wef 01/10/2020] |
| “specified organ” has the same meaning as in the Human Organ Transplant Act (Cap. 131A); |
| “specified out-patient treatment” means any out-patient medical treatment or out-patient psychiatric treatment, approved by the Minister for Health for the purposes of regulation 21B; |
| “surgical treatment” means any surgical treatment approved by the Minister for Health for the purposes of this Part; [S 855/2020 wef 01/10/2020] |
| “Third Schedule treatment” means any medical treatment specified in the Third Schedule; |
| “treatment for sexual sterilization” has the same meaning as in the Voluntary Sterilization Act (Cap. 347); |
| “treatment of neoplasms by chemotherapy” means the administration of tested and approved chemotherapeutic agents by the usual and known routes in the treatment of malignant and benign neoplasms, and neoplasms of uncertain behaviour. |
[S 855/2020 wef 01/10/2020] | (2) In this Part, unless the context otherwise requires, a reference to any medical treatment, psychiatric treatment, approved rehabilitation treatment, home palliative care or approved screening includes a reference to any medical treatment, psychiatric treatment, approved rehabilitation treatment, home palliative care or approved screening (as the case may be) received, or to be received, as part of an approved treatment package. [S 855/2020 wef 01/10/2020] |
| (3) In this Part, unless the context otherwise requires, a reference to a person receiving any medical treatment, psychiatric treatment, approved rehabilitation treatment, home palliative care or approved screening on or after a certain date shall include a reference to that person receiving any medical treatment, psychiatric treatment, approved rehabilitation treatment, home palliative care or approved screening (as the case may be) on or after that date as part of an approved treatment package under which the first medical treatment, psychiatric treatment, approved rehabilitation treatment, home palliative care or approved screening (as the case may be) was received before that date. [S 855/2020 wef 01/10/2020] |
[S 855/2020 wef 01/10/2020] |